J&J Ordered to pay $417 Million in Ovarian Cancer Case

J&J Ordered to pay $417 Million in Ovarian Cancer Case

Defendant Johnson and Johnson [corporate website] now faces [Reuters report] about 4,800 claims regarding the company's failure to warn consumers of cancer risks linked to such products.

A woman accused Johnson & Johnson that she developed ovarian cancer because of the use of the baby talc so, Johnson & Johnson has been ordered to pay $417m to that woman.

Internal documents were entered into evidence at trial that indicated Johnson & Johnson knew about the risks of the use of talc and link to ovarian cancer for decades - and failed to warn women of those risks.

Fix works silence Big Ben until 2021
A brick enclosure in the tower will also be replaced with glass to allow Big Ben to be viewed by people walking up the staircase. Even more scathing was Tory MP Conor Burns, who suggested that most of MPs anxious about Big Ben were has-beens.

The plaintiff in the Los Angeles case, 62-year-old Eva Echeverria, told the jury that had Johnson & Johnson placed a similar warning on its baby powder, she would not have used it.

Johnson & Johnson (NYSE:JNJ) could be at risk of billions of dollars in lawsuits, following a key ruling in a lawsuit linking its signature baby powder with certain types of cancer.

Mrs. Echeverria developed ovarian cancer as a "proximate result of the unreasonably risky and defective nature of talcum powder", she said in her lawsuit.

Qatar 'has not yet given permission for pilgrim flights'
A fire broke out in a hotel in the Saudi city Makkah on Monday, sparking alarm among Haj pilgrims, an official said on Monday. But even as Doha cautiously welcomed the reopening of the border, it blasted the move as "politically motivated".

The jury's award included $68 million in compensatory damages and $340 million in punitive damages, Mr. Robinson said. She was diagnosed with ovarian cancer in 2007. It followed several trials in Missouri state court that resulted in more than $300 million in verdicts against J&J.

Johnson & Johnson declined to comment on the verdict, but Carol Goodrich, Johnson & Johnson's spokeswoman, said in a statement that the company will appeal the verdict. Some studies have found a small to moderate increase in cancer risk, but these studies tend to rely on women self-reporting. And their blood test shows ovarian cancer early.

About Bernstein Liebhard LLP Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. But as the American Cancer Society notes, those kinds of studies can be biased because they rely on a person's memory of talc use years after the fact. Because all the cases show that it increases the risk of ovarian cancer. J&J has consistently disputed those allegations and says the science "supports the safety" of the product. "There's a problem all over the country with women using talcum powder on a daily basis for 10, 20, 30, 40 years".

Hibbett Sports, Inc. (HIBB) Hits 52-Week Low
On average, equities research analysts forecast that Hibbett Sports will post $1.74 earnings per share for the current year. Norges Bank bought a new position in shares of Hibbett Sports during the fourth quarter worth approximately $7,390,000.

The lawsuit suspected that the company has the knowledge of the risk of the cancer due to the use of talcum powder but the company obscured this from the public.

Related Articles